Today: 2 July 2026
Salesforce Stock Jumps as Agentforce AI Revenue Scorecard Gets a Reset

Salesforce Stock Jumps as Agentforce AI Revenue Scorecard Gets a Reset

SAN FRANCISCO, May 2, 2026, 07:03 (PDT)

Starting in fiscal 2027, Salesforce Inc. plans to consolidate its AI-related revenue reporting into two buckets, making it simpler for investors to track Agentforce and Data 360 performance as the company aims to show its AI business can drive future growth. Shares finished Friday’s session at $183.82, up 4.13%.

This shift is significant: investors aren’t buying into sweeping AI promises anymore—they’re demanding actual numbers from software makers. Agentforce, Salesforce’s lineup of AI-powered agents, is designed to automate tasks with less hands-on work from people. As for Data 360, that’s the data platform that feeds these agents the business context they need.

The timing isn’t great for enterprise software players. Just last month, Reuters pointed out that worries around AI have taken a toll, with Salesforce, ServiceNow and Workday all facing questions: can AI actually drive new sales, or will it just erode demand for standard offerings?

On Friday, Salesforce announced plans to break out its revenue figures into “Agentforce Apps” and “Data 360, Platform & Other.” The company also said it would release restated numbers for fiscal 2025 and 2026, allowing analysts to track year-on-year changes more easily. Business Wire

The figures make clear why eyes are turning to the platform segment. Looking at Salesforce’s reworked fiscal 2026 numbers, Agentforce Apps brought in $26.7 billion in subscription and support revenue. Data 360, Platform & Other posted $12.7 billion. Stripping out currency effects, Agentforce Apps grew 7%, while Data 360, Platform & Other clocked 15% growth.

Evercore ISI’s Kirk Materne pointed out that attention is shifting to just “two key segments” now. Sales, service, marketing, and commerce fall under Agentforce Apps, while data, Informatica, Mule, and Tableau are collected under the platform umbrella. Investors.com

Investors saw it as a clearer setup, not a resolution. Salesforce outperformed ServiceNow, which ended up 3.23%, but lagged Oracle’s 6.47% jump. That points to broader buying across major software stocks.

Back in February, Salesforce started shifting its story. The company reported that annual recurring revenue for Agentforce and Data 360 topped $2.9 billion, breaking out $800 million for Agentforce alone. Since launch, Agentforce deals have cleared 29,000, Salesforce said.

Salesforce chair and CEO Marc Benioff said at the time that Agentforce had already processed almost 20 trillion tokens, outputting more than 2.4 billion agentic work units—AI, as he put it, “delivering real work.” President and CFO Robin Washington told investors the company was looking for organic revenue growth to pick up again in the second half of fiscal 2027. SEC

There’s a catch with the new format. Salesforce will keep giving constant-currency growth rates based on its old product lineup up to fiscal 2027. After that—starting fiscal 2028—the company switches over entirely to the new structure, dropping the old breakdown. That means investors could lose visibility into legacy lines like marketing, commerce, MuleSoft, or Tableau as years go on.

Salesforce’s cautionary statements flag the same problem. The company called out risks tied to AI rollouts, fresh features, regulations, and the rapid pace of change in enterprise cloud — all moving parts for software customers weighing budgets for agents, data tools, or current cloud software.

Right now, Salesforce is offering Wall Street less segmentation and clearer AI categories. That shift could work in the stock’s favor. But it also sets up the next earnings report for a straightforward test: will Agentforce Apps and Data 360 deliver growth that supports the narrative?

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Regencell Bioscience (RGC) Drops Sharply, Trades Far Below May Offer Price as Sector Moves Up
    July 2, 2026, 11:17 AM EDT. Regencell Bioscience Holdings (NASDAQ:RGC) slid 6.6% to $7.50, now down 63% from the $20.30 price of its May registered-direct deal. That slump stands out with biotech names like iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) gaining 1.9%. RGC traded in a wide 25.1% range, topping out at $9.31 during the session but still far off the May offer. The company raised around $20 million in the offering, which saw a big institutional player take the lead. Regencell posted a $5.3 million net loss for the six months to December 2025, with R&D spend limited at $416,030. CEO Yat-Gai Au keeps a tight grip, holding 88.6% of the stock, as the firm works on TCM treatments for ADHD and autism.
Blackstone Inc. Creates N1 AI Unit Around OpenAI, Anthropic Bets as Credit Fund Faces Pressure
Previous Story

Blackstone Inc. Creates N1 AI Unit Around OpenAI, Anthropic Bets as Credit Fund Faces Pressure

McDonald’s Corporation Stock Slides Before Q1 Earnings as Value Menu Faces Wall Street Test
Next Story

McDonald’s Corporation Stock Slides Before Q1 Earnings as Value Menu Faces Wall Street Test

Go toTop